Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1987 Jun 27;294(6588):1648–1651. doi: 10.1136/bmj.294.6588.1648

Influence of proteinuria on vascular disease, blood pressure, and lipoproteins in insulin dependent diabetes mellitus.

P H Winocour, P N Durrington, M Ishola, D C Anderson, H Cohen
PMCID: PMC1246823  PMID: 3113568

Abstract

Patients with insulin dependent diabetes mellitus who develop proteinuria may die prematurely, whereas those who do not develop this complication have a comparatively normal life span. The excess mortality in diabetics with proteinuria is from cardiovascular as well as renal disease, but the reason is unclear. Risk factors for vascular disease were therefore assessed in 22 insulin dependent diabetics with proteinuria, but not renal failure, who were matched for sex, age, duration of diabetes, and glycated haemoglobin (HbA1) values with a similar number who had normal urinary albumin excretion rates. Macrovascular disease (ischaemic heart disease and peripheral vascular disease) was present in 10 patients with proteinuria but in only three with normal albumin excretion rates, and proliferative retinopathy was detected in 11 and four patients in the two groups. There was no significant excess of smokers in the group with proteinuria. Blood pressure was, however, higher in the patients with proteinuria--mean systolic pressure 161 (SD 18) mm Hg compared with 135 (19) mm Hg (95% confidence interval of difference between means 15 to 38 mm Hg); mean diastolic pressure 90 (SD 12) mm Hg compared with 79 (15) mm Hg (confidence interval 3 to 19 mm Hg). The concentration of serum high density lipoprotein (HDL) cholesterol isolated by precipitation was lower in the patients with proteinuria (confidence interval 0.02 to 0.41 mmol/l). Their concentration of HDL2 cholesterol isolated by ultracentrifugation was also decreased (confidence interval 0.02 to 0.40 mmol/l), whereas HDL3 cholesterol tended to be increased (confidence interval -0.01 to 0.23 mmol/l). There was also a trend for serum cholesterol concentrations to be higher in the presence of proteinuria (confidence interval -0.39 to 1.20 mmol/l). The aggregation of risk factors for atherosclerosis in insulin dependent diabetes mellitus complicated by proteinuria helps to explain the increased prevalence of ischaemic heart disease and peripheral vascular disease reported in these patients. Early renal disease in insulin dependent diabetes may have an important role in hypertension and altered lipoprotein metabolism.

Full text

PDF
1648

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersen A. R., Christiansen J. S., Andersen J. K., Kreiner S., Deckert T. Diabetic nephropathy in Type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia. 1983 Dec;25(6):496–501. doi: 10.1007/BF00284458. [DOI] [PubMed] [Google Scholar]
  2. Borch-Johnsen K., Andersen P. K., Deckert T. The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1985 Aug;28(8):590–596. doi: 10.1007/BF00281993. [DOI] [PubMed] [Google Scholar]
  3. Burstein M., Scholnick H. R., Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res. 1970 Nov;11(6):583–595. [PubMed] [Google Scholar]
  4. Cruickshanks K. J., Orchard T. J., Becker D. J. The cardiovascular risk profile of adolescents with insulin-dependent diabetes mellitus. Diabetes Care. 1985 Mar-Apr;8(2):118–124. doi: 10.2337/diacare.8.2.118. [DOI] [PubMed] [Google Scholar]
  5. Dornan T. L., Carter R. D., Bron A. J., Turner R. C., Mann J. I. Low density lipoprotein cholesterol: an association with the severity of diabetic retinopathy. Diabetologia. 1982 Mar;22(3):167–170. doi: 10.1007/BF00283746. [DOI] [PubMed] [Google Scholar]
  6. Durrington P. N. A comparison of three methods of measuring serum high density lipoprotein cholesterol in diabetics and non-diabetics. Ann Clin Biochem. 1980 Jul;17(4):199–204. doi: 10.1177/000456328001700408. [DOI] [PubMed] [Google Scholar]
  7. Durrington P. N. Serum high density lipoprotein cholesterol in diabetes mellitus: an analysis of factors which influence its concentration. Clin Chim Acta. 1980 May 21;104(1):11–23. doi: 10.1016/0009-8981(80)90130-8. [DOI] [PubMed] [Google Scholar]
  8. Durrington P. N. Serum high density lipoprotein cholesterol subfractions in type I (insulin-dependent) diabetes mellitus. Clin Chim Acta. 1982 Mar 26;120(1):21–28. doi: 10.1016/0009-8981(82)90073-0. [DOI] [PubMed] [Google Scholar]
  9. Durrington P. N., Whicher J. T., Warren C., Bolton C. H., Hartog M. A comparison of methods for the immunoassay of serum apolipoprotein B in man. Clin Chim Acta. 1976 Aug 16;71(1):95–108. doi: 10.1016/0009-8981(76)90280-1. [DOI] [PubMed] [Google Scholar]
  10. Eckel R. H., McLean E., Albers J. J., Cheung M. C., Bierman E. L. Plasma lipids and microangiopathy in insulin-dependent diabetes mellitus. Diabetes Care. 1981 Jul-Aug;4(4):447–453. doi: 10.2337/diacare.4.4.447. [DOI] [PubMed] [Google Scholar]
  11. Feldt-Rasmussen B. Increased transcapillary escape rate of albumin in type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia. 1986 May;29(5):282–286. doi: 10.1007/BF00452063. [DOI] [PubMed] [Google Scholar]
  12. Fielding B. A., Price D. A., Houlton C. A. Enzyme immunoassay for urinary albumin. Clin Chem. 1983 Feb;29(2):355–357. [PubMed] [Google Scholar]
  13. Friedewald W. T., Levy R. I., Fredrickson D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 Jun;18(6):499–502. [PubMed] [Google Scholar]
  14. Garcia M. J., McNamara P. M., Gordon T., Kannel W. B. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes. 1974 Feb;23(2):105–111. doi: 10.2337/diab.23.2.105. [DOI] [PubMed] [Google Scholar]
  15. Glass C. K., Pittman R. C., Keller G. A., Steinberg D. Tissue sites of degradation of apoprotein A-I in the rat. J Biol Chem. 1983 Jun 10;258(11):7161–7167. [PubMed] [Google Scholar]
  16. HAVEL R. J., EDER H. A., BRAGDON J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955 Sep;34(9):1345–1353. doi: 10.1172/JCI103182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hasslacher C., Stech W., Wahl P., Ritz E. Blood pressure and metabolic control as risk factors for nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia. 1985 Jan;28(1):6–11. doi: 10.1007/BF00276992. [DOI] [PubMed] [Google Scholar]
  18. Hulley S. B., Rosenman R. H., Bawol R. D., Brand R. J. Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease. N Engl J Med. 1980 Jun 19;302(25):1383–1389. doi: 10.1056/NEJM198006193022503. [DOI] [PubMed] [Google Scholar]
  19. Jarrett R. J., Shipley M. J. Mortality and associated risk factors in diabetics. Acta Endocrinol Suppl (Copenh) 1985;272:21–26. doi: 10.1530/acta.0.110s021. [DOI] [PubMed] [Google Scholar]
  20. Kessler I. I. Mortality experience of diabetic patients. A twenty-six-year follow-up study. Am J Med. 1971 Dec;51(6):715–724. doi: 10.1016/0002-9343(71)90299-3. [DOI] [PubMed] [Google Scholar]
  21. Kverneland A., Feldt-Rasmussen B., Vidal P., Welinder B., Bent-Hansen L., Søegaard U., Deckert T. Evidence of changes in renal charge selectivity in patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1986 Sep;29(9):634–639. doi: 10.1007/BF00869262. [DOI] [PubMed] [Google Scholar]
  22. Mallick N. P., Short C. D. The nephrotic syndrome and ischaemic heart disease. Nephron. 1981;27(2):54–57. doi: 10.1159/000182024. [DOI] [PubMed] [Google Scholar]
  23. Mathiesen E. R., Oxenbøll B., Johansen K., Svendsen P. A., Deckert T. Incipient nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia. 1984 Jun;26(6):406–410. doi: 10.1007/BF00262210. [DOI] [PubMed] [Google Scholar]
  24. Moorhead J. F., Chan M. K., El-Nahas M., Varghese Z. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet. 1982 Dec 11;2(8311):1309–1311. doi: 10.1016/s0140-6736(82)91513-6. [DOI] [PubMed] [Google Scholar]
  25. Mühlhauser I., Sawicki P., Berger M. Cigarette-smoking as a risk factor for macroproteinuria and proliferative retinopathy in type 1 (insulin-dependent) diabetes. Diabetologia. 1986 Aug;29(8):500–502. doi: 10.1007/BF00453501. [DOI] [PubMed] [Google Scholar]
  26. Nielsen M. M., Hjøllund E. Smoking and diabetic microangiopathy. Lancet. 1978 Sep 2;2(8088):533–534. doi: 10.1016/s0140-6736(78)92267-5. [DOI] [PubMed] [Google Scholar]
  27. Nikkilä E. A. High density lipoproteins in diabetes. Diabetes. 1981;30(Suppl 2):82–87. [PubMed] [Google Scholar]
  28. Nikkilä E. A., Hormila P. Serum lipids and lipoproteins in insulin-treated diabetes. Demonstration of increased high density lipoprotein concentrations. Diabetes. 1978 Nov;27(11):1078–1086. doi: 10.2337/diab.27.11.1078. [DOI] [PubMed] [Google Scholar]
  29. Parving H. H., Andersen A. R., Smidt U. M., Oxenbøll B., Edsberg B., Christiansen J. S. Diabetic nephropathy and arterial hypertension. Diabetologia. 1983 Jan;24(1):10–12. doi: 10.1007/BF00275939. [DOI] [PubMed] [Google Scholar]
  30. Sayres M., Wyshak G., Denterlein G., Apfel R., Shore E., Federman D. Pregnancy during residency. N Engl J Med. 1986 Feb 13;314(7):418–423. doi: 10.1056/NEJM198602133140705. [DOI] [PubMed] [Google Scholar]
  31. Shore V. G., Forte T., Licht H., Lewis S. B. Serum and urinary lipoproteins in the human nephrotic syndrome: evidence for renal catabolism of lipoproteins. Metabolism. 1982 Mar;31(3):258–268. doi: 10.1016/0026-0495(82)90062-2. [DOI] [PubMed] [Google Scholar]
  32. Smaby J. M., Baumann W. J., Brockman H. L. Lipid structure and the behavior of cholesteryl esters in monolayer and bulk phases. J Lipid Res. 1979 Aug;20(6):784–788. [PubMed] [Google Scholar]
  33. Sosenko J. M., Breslow J. L., Miettinen O. S., Gabbay K. H. Hyperglycemia and plasma lipid levels: a prospective study of young insulin-dependent diabetic patients. N Engl J Med. 1980 Mar 20;302(12):650–654. doi: 10.1056/NEJM198003203021202. [DOI] [PubMed] [Google Scholar]
  34. Telmer S., Christiansen J. S., Andersen A. R., Nerup J., Deckert T. Smoking habits and prevalence of clinical diabetic microangiopathy in insulin-dependent diabetics. Acta Med Scand. 1984;215(1):63–68. doi: 10.1111/j.0954-6820.1984.tb04970.x. [DOI] [PubMed] [Google Scholar]
  35. Valdorf-Hansen F. Coagulability in diabetics. Acta Med Scand Suppl. 1967;476:147–157. doi: 10.1111/j.0954-6820.1967.tb12693.x. [DOI] [PubMed] [Google Scholar]
  36. Vannini P., Ciavarella A., Flammini M., Bargossi A. M., Forlani G., Borgnino L. C., Orsoni G. Lipid abnormalities in insulin-dependent diabetic patients with albuminuria. Diabetes Care. 1984 Mar-Apr;7(2):151–154. doi: 10.2337/diacare.7.2.151. [DOI] [PubMed] [Google Scholar]
  37. Viberti G. C., Hill R. D., Jarrett R. J., Argyropoulos A., Mahmud U., Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet. 1982 Jun 26;1(8287):1430–1432. doi: 10.1016/s0140-6736(82)92450-3. [DOI] [PubMed] [Google Scholar]
  38. West K. M., Ahuja M. M., Bennett P. H., Czyzyk A., De Acosta O. M., Fuller J. H., Grab B., Grabauskas V., Jarrett R. J., Kosaka K. The role of circulating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes Care. 1983 Jul-Aug;6(4):361–369. doi: 10.2337/diacare.6.4.361. [DOI] [PubMed] [Google Scholar]
  39. Winocour P. H., Durrington P. N., Ishola M., Anderson D. C. Lipoprotein abnormalities in insulin-dependent diabetes mellitus. Lancet. 1986 May 24;1(8491):1176–1178. doi: 10.1016/s0140-6736(86)91159-1. [DOI] [PubMed] [Google Scholar]
  40. Wiseman M., Viberti G., Mackintosh D., Jarrett R. J., Keen H. Glycaemia, arterial pressure and micro-albuminuria in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1984 Jun;26(6):401–405. doi: 10.1007/BF00262209. [DOI] [PubMed] [Google Scholar]
  41. Witztum J. L., Fisher M., Pietro T., Steinbrecher U. P., Elam R. L. Nonenzymatic glucosylation of high-density lipoprotein accelerates its catabolism in guinea pigs. Diabetes. 1982 Nov;31(11):1029–1032. doi: 10.2337/diacare.31.11.1029. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES